![]() |
||||
|
||||
|
|
||||
Re: Active management - third stageFrom: Barbara Nicol MD (blnicol@ix.netcom.com)Tue Oct 11 19:38:57 2005
At our hospital, we routinely use oxytocin (20 U/1000 cc) wide open after cord clamping or alternately 10 U IM if no IV is present. The exceptions are patient refusal (usually because she desires as natural an experience as possible) or no antepartum ultrasound (in other words, if the pregnancy is not known to be singleton). We did this after reviewing the literature you mention at the departmental level. It seems odd to me that there are actually 3 well-conducted RCTs of oxytocics in 3rd stage showing benefit and few do it. However, I understand that UCSF and SF General have also adopted similar practices recently. The usual "reasons" given by US authorities for avoiding oxytocics in 3rd stage are (1) undiagnosed 2nd twin - not likely now with nearly 100% ultrasound - and (2) retained placenta - which has been disproven by the RCTs - except perhaps for ergot alkaloids which may cause retained placenta. We chose IV because many of our patients do have an IV and why stick another needle into the patient at such a moment? - Barb
At Tue, 11 Oct 2005, RModugno@aol.com wrote:
>
-- Barbara Nicol MD St. Luke's Health Care Center San Francisco CA USA
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Thu Oct 2 04:50:21 2008 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.